Hailey-Hailey disease (benign familial pemphigus) responsive to treatment with ocrelizumab for multiple sclerosis

Br J Dermatol. 2023 Jul 17;189(2):232-234. doi: 10.1093/bjd/ljad101.
No abstract available

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Humans
  • Multiple Sclerosis* / drug therapy
  • Pemphigus*
  • Pemphigus, Benign Familial* / drug therapy

Substances

  • ocrelizumab
  • Antibodies, Monoclonal, Humanized